Volume 13, Number 8—August 2007
Dispatch
Invasive Meningococcal Disease, Utah, 1995–2005
Rachelle B. Boulton*†
, Stephen C. Alder*, Susan Mottice†, A. Peter Catinella*, and Carrie L. Byington†
, Stephen C. Alder*, Susan Mottice†, A. Peter Catinella*, and Carrie L. Byington†Table 2
Serogroup distribution of invasive meningococcal disease by period*
| Neisseria meningitidis serogroup | Period 1 |
Period 2 |
|||||
|---|---|---|---|---|---|---|---|
| Utah | United States | p value | Utah | United States | p value | ||
| B | 32.1% | 29.2% | 0.5701 | 11.3% | 39.7% | 0.0002 | |
| Y | 26.1% | 32.0% | 0.2773 | 50.0% | 23.9% | <0.0001 | |
| C | 25.0% | 25.5% | 0.9298 | 15.9% | 21.4% | 0.3783 | |
| Other | 16.7% | 13.4% | 0.4084 | 22.7% | 15.0% | 0.1633 | |
*Period 1, 1995–1999; period 2, 2000–2005. US data estimates based on information collected from Active Bacterial Core surveillance sites.
